The global induced pluripotent stem cell (iPSC) market was valued at USD 2.1 billion in 2023, growing at a CAGR of 9.6% from 2024 to 2033. The market is expected to reach USD 5.2 billion by 2033. Due to the growing need for vaccine production, higher expenditures in the industry, and an expanding application portfolio from ongoing research and development efforts, the iPSC market is expanding quickly.
La Jolla Transport Co
Go88
Kqbd14 Cat
Kèo Bóng Đá
Mm99
100vip
Xolac Tv
Kèo Nhà Cái
Mua Gmail Muagmailnet
100vip